APPLICATION SITE CYST

This adverse event was reported 13 times

APPLICATION SITE CYST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIHYDROERGOTAMINE MESYLATE 1 0.0007
1 TAPINAROF 1 0.0005
2 SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE 1 0.0001
3 MINOXIDIL 5 0.0001
4 NILOTINIB 1 0.0000
See all drugs enriched for association with APPLICATION SITE CYST

These drug classes are most commonly taken by patients reporting APPLICATION SITE CYST:

# Drug class Count
0 Arteriolar Vasodilator [EPC] 5
1 5-alpha Reductase Inhibitor [EPC] 3
2 Aryl Hydrocarbon Receptor Agonist [EPC] 1
See all common drug classes associated with APPLICATION SITE CYST

APPLICATION SITE CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aryl Hydrocarbon Receptor Agonist [EPC] 1 0.0005
1 Arteriolar Vasodilator [EPC] 5 0.0001
2 5-alpha Reductase Inhibitor [EPC] 3 0.0000
See all drug classes enriched for association with APPLICATION SITE CYST